Can CRP Be High in Fungal Infections?
Yes, C-reactive protein (CRP) can be markedly elevated in fungal infections, often reaching levels >100 mg/L in invasive disease, similar to bacterial infections.
CRP Elevation Patterns in Fungal Infections
CRP rises substantially in fungal infections, particularly in immunocompromised patients with invasive disease. The elevation pattern depends on the type and severity of infection:
Invasive Fungal Infections
- Deep-seated fungal infections produce CRP levels of 104-380 mg/L in approximately 76% of cases 1
- Fungal septicemia generates CRP values of 17-284 mg/L before or within days of positive blood cultures 1
- Fungal pneumonia in hematologic malignancy patients shows median CRP of 22.3 mg/dL (significantly higher than non-fungal pneumonia at 7.3 mg/dL) 2
Localized Fungal Infections
- Fungal esophagitis: Peak CRP ranges 73-380 mg/L (mean 170 mg/L) 3
- Fungal enterocolitis: Peak CRP ranges 54-225 mg/L (mean 146 mg/L) 3
- Uncomplicated fungal stomatitis in immunocompromised patients: 37% show CRP 110-320 mg/L, though many remain <100 mg/L 1
Important caveat: Fungal stomatitis in immunocompetent patients typically shows no CRP elevation 1, highlighting that immune status significantly affects the inflammatory response.
Clinical Utility: Distinguishing Fungal from Bacterial Infections
The key diagnostic insight is not whether CRP is elevated, but rather the combination of high CRP with low procalcitonin (PCT):
The Diagnostic Pattern
High CRP (>100-120 mg/L) combined with low PCT (<0.5-1.25 μg/L) strongly suggests fungal rather than bacterial infection in immunocompromised patients 4, 5:
- This combination offers 81% specificity and 85% sensitivity for fungal infections 4
- The pattern works because bacterial infections (especially gram-negative) typically elevate both CRP and PCT markedly, while fungal infections elevate CRP but minimally affect PCT 4
Practical Algorithm
When evaluating an immunocompromised febrile patient:
- Measure both CRP and PCT at fever onset and over 48 hours
- CRP >120 mg/L + PCT <1.25 μg/L → Consider invasive fungal infection (ROC AUC 0.962) 5
- CRP >10 mg/dL in pulmonary infiltrates → Fungal pneumonia more likely than bacterial 2
- Serial CRP monitoring helps assess treatment response—declining CRP indicates successful antifungal therapy 3
Common Pitfalls
- Don't assume normal CRP rules out fungal infection: Some patients, particularly with transient fungemia or superficial infections in immunocompetent hosts, may not mount significant CRP responses 1
- Don't rely on CRP alone: The diagnostic power comes from the CRP/PCT combination, not CRP in isolation 4, 5
- Consider immune status: The magnitude of CRP elevation correlates with immune competence—severely immunosuppressed patients may have blunted responses despite invasive disease 6
- Beware of cross-reactivity: Beta-D-glucan and galactomannan tests can have false positives from bacterial infections or contaminants, so integrate CRP/PCT patterns with fungal biomarkers 6
Monitoring Treatment Response
CRP serves as a useful marker for treatment efficacy. Successful antifungal therapy leads to:
- Progressive decline in CRP levels over days to weeks 3
- Failure of CRP to decline despite therapy suggests treatment failure, resistance, or persistent infection 3
This makes serial CRP measurements valuable for both diagnosis and therapeutic monitoring in fungal infections 3.